[Bora] Announcement of Elected Directors (Including Independent Directors) in the Full Board Election at the 115th Annual General Meeting
Key facts
- [Bora] Announcement of Elected Directors (Including Independent Directors) in the Full Board Election at the 115th Annual General Meeting
- Bora Pharmaceuticals announced on June 9, 115, the results of its full board election following the expiration of terms. While there were changes in some board members, the company's overall operations and strategic direction are expected to remain stable.
- Source: PR Times
- Date: June 9, 2026
Direct answer
Bora Pharmaceuticals announced on June 9, 115, the results of its full board election following the expiration of terms. While there were changes in some board members, the company's overall operations and strategic direction are expected to remain stable.
- Citation
- [Bora] Announcement of Elected Directors (Including Independent Directors) in the Full Board Election at the 115th Annual General Meeting (June 9, 2026), PR Times
- Source
- PR Times
- Date
- June 9, 2026
Bora Pharmaceuticals announced on June 9, 115, the results of its full board election following the expiration of terms. While there were changes in some board members, the company's overall operations and strategic direction are expected to remain stable.
📋 Article Processing Timeline
- 📰 Published: June 9, 2026 at 09:00
- 🔍 Collected: June 10, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: June 12, 2026 at 17:53 (57h 53m after Collected)
1. Date of Change: 115/06/09
2. Type of Personnel Elected or Changed (Please enter Corporate Director, Corporate Supervisor, Independent Director, Natural Person Director, or Natural Person Supervisor): Independent Director, Natural Person Director
3. Former Personnel's Title and Name:
(1) Director: Sheng Bao-Xi
(2) Director: Ta Ya Venture Capital Co., Ltd.
(3) Director: Borei International Co., Ltd., represented by Chen Guan-Bai
(4) Independent Director: Li Yi-Chin
(5) Independent Director: Lin Rui-Yi
(6) Independent Director: Lai Ming-Rong
(7) Independent Director: Lin Hsin-Yi
4. Former Personnel's Biography:
(1) Director: Sheng Bao-Xi, Chairman of the Company
(2) Director: Ta Ya Venture Capital Co., Ltd., Director of the Company
(3) Director: Borei International Co., Ltd., represented by Chen Guan-Bai, Chairman of Bai Chuan International Investment Co., Ltd.
(4) Independent Director: Li Yi-Chin, Managing Director of Blue Ocean Asia
(5) Independent Director: Lin Rui-Yi, General Manager of Shun Yi Trading Co., Ltd.
(6) Independent Director: Lai Ming-Rong, Lecturer at the Insurance Promotion Institute
(7) Independent Director: Lin Hsin-Yi, Partner at Zhong Bo Law Firm
5. New Personnel's Title and Name:
(1) Director: Sheng Bao-Xi
(2) Director: Borei International Co., Ltd., represented by Chen Guan-Bai
(3) Director: Wang Jin-Ju
(4) Independent Director: Li Yi-Chin
(5) Independent Director: Lai Ming-Rong
(6) Independent Director: Lin Hsin-Yi
(7) Independent Director: Chiu Chi-Hua
6. New Personnel's Biography:
(1) Director: Sheng Bao-Xi, Chairman of the Company
(2) Director: Borei International Co., Ltd., represented by Chen Guan-Bai, Chairman of Bai Chuan International Investment Co., Ltd.
(3) Director: Wang Jin-Ju, Chief Financial Officer of the Company
(4) Independent Director: Li Yi-Chin, Managing Director of Blue Ocean Asia
(5) Independent Director: Lai Ming-Rong, Lecturer at the Insurance Promotion Institute
(6) Independent Director: Lin Hsin-Yi, Partner at Zhong Bo Law Firm
(7) Independent Director: Chiu Chi-Hua, Founder of 43 Ventures
7. Change Situation (Please enter 'Resignation', 'Dismissal', 'Term Expiration', 'Death', or 'New Appointment'): Term Expiration.
8. Reason for Change: Term expiration, full re-election.
9. Shareholding of New Personnel at the Time of Election:
(1) Director: Sheng Bao-Xi, 6,398,353 shares
(2) Director: Borei International Co., Ltd., 22,442,026 shares
(3) Director: Wang Jin-Ju, 255,139 shares
(4) Independent Director: Li Yi-Chin, 0 shares
(5) Independent Director: Lai Ming-Rong, 0 shares
(6) Independent Director: Lin Hsin-Yi, 0 shares
(7) Independent Director: Chiu Chi-Hua, 0 shares
10. Original Term (e.g., xx/xx/xx ~ xx/xx/xx): 112/06/06~115/06/05
11. Effective Date of New Appointment: 115/06/09
12. Proportion of Director Changes in the Same Term: Not applicable due to full re-election.
13. Proportion of Independent Director Changes in the Same Term: Not applicable due to full re-election.
14. Proportion of Supervisor Changes in the Same Term: Not applicable due to full re-election.
15. Whether more than one-third of the directors have changed (Please enter Yes or No): No
16. Other Matters to be Noted (If the subject of the event or resolution is a publicly issued or above company, this material information also meets the criteria of Article 7, Paragraph 6 of the Regulations Governing the Application of the Securities Transaction Act regarding matters that have a significant impact on shareholder equity or securities prices): None
Keywords: Material Information
2. Type of Personnel Elected or Changed (Please enter Corporate Director, Corporate Supervisor, Independent Director, Natural Person Director, or Natural Person Supervisor): Independent Director, Natural Person Director
3. Former Personnel's Title and Name:
(1) Director: Sheng Bao-Xi
(2) Director: Ta Ya Venture Capital Co., Ltd.
(3) Director: Borei International Co., Ltd., represented by Chen Guan-Bai
(4) Independent Director: Li Yi-Chin
(5) Independent Director: Lin Rui-Yi
(6) Independent Director: Lai Ming-Rong
(7) Independent Director: Lin Hsin-Yi
4. Former Personnel's Biography:
(1) Director: Sheng Bao-Xi, Chairman of the Company
(2) Director: Ta Ya Venture Capital Co., Ltd., Director of the Company
(3) Director: Borei International Co., Ltd., represented by Chen Guan-Bai, Chairman of Bai Chuan International Investment Co., Ltd.
(4) Independent Director: Li Yi-Chin, Managing Director of Blue Ocean Asia
(5) Independent Director: Lin Rui-Yi, General Manager of Shun Yi Trading Co., Ltd.
(6) Independent Director: Lai Ming-Rong, Lecturer at the Insurance Promotion Institute
(7) Independent Director: Lin Hsin-Yi, Partner at Zhong Bo Law Firm
5. New Personnel's Title and Name:
(1) Director: Sheng Bao-Xi
(2) Director: Borei International Co., Ltd., represented by Chen Guan-Bai
(3) Director: Wang Jin-Ju
(4) Independent Director: Li Yi-Chin
(5) Independent Director: Lai Ming-Rong
(6) Independent Director: Lin Hsin-Yi
(7) Independent Director: Chiu Chi-Hua
6. New Personnel's Biography:
(1) Director: Sheng Bao-Xi, Chairman of the Company
(2) Director: Borei International Co., Ltd., represented by Chen Guan-Bai, Chairman of Bai Chuan International Investment Co., Ltd.
(3) Director: Wang Jin-Ju, Chief Financial Officer of the Company
(4) Independent Director: Li Yi-Chin, Managing Director of Blue Ocean Asia
(5) Independent Director: Lai Ming-Rong, Lecturer at the Insurance Promotion Institute
(6) Independent Director: Lin Hsin-Yi, Partner at Zhong Bo Law Firm
(7) Independent Director: Chiu Chi-Hua, Founder of 43 Ventures
7. Change Situation (Please enter 'Resignation', 'Dismissal', 'Term Expiration', 'Death', or 'New Appointment'): Term Expiration.
8. Reason for Change: Term expiration, full re-election.
9. Shareholding of New Personnel at the Time of Election:
(1) Director: Sheng Bao-Xi, 6,398,353 shares
(2) Director: Borei International Co., Ltd., 22,442,026 shares
(3) Director: Wang Jin-Ju, 255,139 shares
(4) Independent Director: Li Yi-Chin, 0 shares
(5) Independent Director: Lai Ming-Rong, 0 shares
(6) Independent Director: Lin Hsin-Yi, 0 shares
(7) Independent Director: Chiu Chi-Hua, 0 shares
10. Original Term (e.g., xx/xx/xx ~ xx/xx/xx): 112/06/06~115/06/05
11. Effective Date of New Appointment: 115/06/09
12. Proportion of Director Changes in the Same Term: Not applicable due to full re-election.
13. Proportion of Independent Director Changes in the Same Term: Not applicable due to full re-election.
14. Proportion of Supervisor Changes in the Same Term: Not applicable due to full re-election.
15. Whether more than one-third of the directors have changed (Please enter Yes or No): No
16. Other Matters to be Noted (If the subject of the event or resolution is a publicly issued or above company, this material information also meets the criteria of Article 7, Paragraph 6 of the Regulations Governing the Application of the Securities Transaction Act regarding matters that have a significant impact on shareholder equity or securities prices): None
Keywords: Material Information
FAQ
What is the purpose of Bora Pharmaceuticals' board election?
This board election is a routine, comprehensive re-election due to the expiration of directors' terms, aiming to ensure the continuity and soundness of corporate governance.
Who are the new independent directors?
The newly elected independent directors include Li Yi-Chin, Lai Ming-Rong, Lin Hsin-Yi, and Chiu Chi-Hua.
Does this board change significantly impact shareholder rights?
According to the announcement, this is a routine full re-election and does not involve changes to more than one-third of the directors, so a significant impact on shareholder rights is not explicitly stated, but board stability is crucial for shareholder interests.
What are Bora Pharmaceuticals' main business activities?
Bora Pharmaceuticals is primarily engaged in the research, development, manufacturing, and sales of pharmaceutical products, with expertise in generics and biosimilars.
What changes are expected in the company's business strategy after this election?
With key members like Chairman Sheng Bao-Xi retained, the company's business strategy is expected to remain stable, continuing to focus on the development and expansion of existing operations.